New anti-angiogenic compound based on chemically modified heparin.

Autor: Kniggendorf V; Department of Ophthalmology and Visual Sciences, Escola Paulista de Medicina, Universidade Federal de São Paulo, Rua Botucatu, 821, 1o andar, São Paulo, SP, 04023-062, Brazil. vinicius_kdorf@yahoo.com.br., Souza MEP; Department of Biochemistry, Molecular Biology Division, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil., Russo T; Department of Biochemistry, Molecular Biology Division, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil., de Lima MA; Department of Ophthalmology and Visual Sciences, Escola Paulista de Medicina, Universidade Federal de São Paulo, Rua Botucatu, 821, 1o andar, São Paulo, SP, 04023-062, Brazil.; Molecular & Structural Biosciences, School of Life Sciences, Keele University, Staffordshire, Newcastle-Under-Lyme, ST5 5BG, UK., Grupenmacher AT; Department of Ophthalmology and Visual Sciences, Escola Paulista de Medicina, Universidade Federal de São Paulo, Rua Botucatu, 821, 1o andar, São Paulo, SP, 04023-062, Brazil., Regatieri CV; Department of Ophthalmology and Visual Sciences, Escola Paulista de Medicina, Universidade Federal de São Paulo, Rua Botucatu, 821, 1o andar, São Paulo, SP, 04023-062, Brazil.; Department of Biochemistry, Molecular Biology Division, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil., Dreyfuss JL; Department of Biochemistry, Molecular Biology Division, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.

Publikováno v: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie [Graefes Arch Clin Exp Ophthalmol] 2022 Dec; Vol. 260 (12), pp. 3847-3855. Date of Electronic Publication: 2022 Sep 13.